1. A suspended sitting apparatus, comprising:
(a) a sitting surface adapted to be suspended in more than one configuration;
(b) wherein the more than one configuration includes:
(i) a basic configuration wherein the sitting apparatus is suspended from two horizontally separated overhead points;
(ii) a single point configuration wherein sitting apparatus is suspended from one overhead point; and
(iii) a vertical configuration, wherein the sitting apparatus is suspended from two points located on a vertical surface.
2. The suspending sitting apparatus of claim 1, further comprising two or more suspension devices adapted to suspend the sitting surface.
3. The suspended sitting apparatus of claim 2, wherein the two or more suspension devices include ropes.
4. The suspended sitting apparatus of claim 2, wherein the two or more suspension devices include carabineers.
5. The suspended sitting apparatus of claim 2, wherein the sitting surface includes a first end and a second end opposite the first end; and wherein at least one suspension device of the two or more suspension devices attaches to each of the first end and the second end.
6. The suspended sitting apparatus of claim 1, wherein in one or more configurations, the suspended sitting apparatus includes a spreader bar.
7. The suspended sitting apparatus of claim 1, wherein in one or more configurations, the suspended sitting apparatus includes one or more rope stops.
8. The suspended sitting apparatus of claim 1, wherein in one or more configurations, the suspended sitting apparatus includes a pivot and a spreader bar; wherein the spreader bar is adapted to attach to the pivot and rotate about the pivot.
9. The suspended sitting apparatus of claim 1, wherein the two horizontally separated overhead points are located on one or more tree branches.
10. The suspended sitting apparatus of claim 1, wherein the one overhead point is located on a tree branch.
11. The suspended sitting apparatus of claim 1, wherein the vertical surface is a tree trunk.
12. A suspended sitting system, comprising:
(a) a sitting surface having a first end and a second end opposite the first end;
(b) one or more suspension points;
(c) a first suspension means for suspending the first end of the sitting surface from the one or more suspension points; and
(d) a second suspension means for suspending the second end of the sitting surface from the one or more suspension points;
(e) wherein the suspended sitting system is capable of more than one suspension configurations, including:
(i) a basic configuration, wherein the one or more suspension points is exactly two generally horizontally-oriented suspension points;
(ii) a single point configuration, wherein the one or more suspension points is exactly one suspension point; and
(iii) a vertical configuration, wherein the one or more suspension points is exactly two vertically oriented suspension points.
13. The suspended sitting system of claim 12, wherein the first suspension means and second suspension means include one or more ropes;
14. The suspended sitting system of claim 12, wherein the first suspension means and second suspension means include one or more carabineers.
15. The suspended sitting system of claim 12, wherein the first suspension means and second suspension means include one or more straps.
16. The suspended sitting system of claim 12, further including a spreader bar spanning between the first suspension means and second suspension means.
17. the suspended sitting system of claim 12, wherein one of the one or more suspension points includes a pivot about which the sitting surface is capable of rotation.
18. A method comprising:
(a) suspending a sitting surface of a suspended sitting apparatus in a first configuration by securing the suspended sitting apparatus at first and second suspension points, the first and second suspension points being generally horizontally spaced;
(b) suspending the sitting surface of the suspended sitting apparatus in a second configuration by securing the suspended sitting apparatus at a third suspension point;
(c) suspending the sitting surface of the suspended sitting apparatus in a third configuration by securing the suspended sitting apparatus at fourth and fifth suspension points, the fourth and fifth suspension points being generally vertically spaced.
19. The method of claim 18, wherein the method further comprises aiming a weapon while sitting on the sitting surface.
20. The method of claim 19, wherein the method further comprises, following said step of aiming a weapon, firing a projectile using the weapon while sitting on the sitting surface.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A compound of formula (I):
wherein:
R1 are R1a are each independently CN, CH3, CF3, CSNH2 or C(\u2550N-Z)-S(O)r-Q;
W and W1, are each independently N or C\u2014R5;
R2 and R2a are each independently halogen, CH3 or NR7R7;
R3 and R3a are each independent (C1-C3)-haloalkyl, (C1-C3)-haloalkoxy or SF5;
R4 and R4a are each independently (C1-C6)-alkyl, (C1-C6)-haloalkyl (C2-C6)-alkenyl, (C2-C6)-haloalkenyl, (C2-C6)-alkynyl or (C2-C6)-haloalkynyl;
A is NR8\u2014Y\u2014NR9, NR8a\u2014CO\u2014CO\u2014NR9a, NR8a\u2014CO\u2014Y1\u2014CO\u2014NR9a,
NR8a\u2014CO\u2014O\u2014Y1\u2014O\u2014CO\u2014NR9a, NR10\u2014C(\u2550X)\u2014NR11, or a formula (E):
or a formula (F);
M is Y, CO\u2014Y1\u2014CO, CO\u2014O\u2014Y1\u2014O\u2014CO, CO\u2014CO, C(\u2550X), S, S2, SO or SO2;
R6 and R7 are each independently H, (C1-C6)-alkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl, which last three mentioned groups are unsubstituted or substituted by one or more radicals selected from the group consisting of halogen (C3-C7)-cycloakyl,
R12, R13, (C1-C6-alkoxy, (C1-C6)-haloalkoxy, OR12 and OR13;
R8 and R9 are each independently H, (C2-C6)-alkenyl, (C2-C6)-haloalkenyl, (C2-C6)-alkynyl, (C2-C6)-haloalkynyl, (C3-C7)-cycloalkyl, CO2\u2014(C1-C6)-alkyl, CO2\u2014(C3-C6)-alkenyl, CO2\u2014(C2-C6)-alkynyl, CO2\u2014(CH2)mR12, CO2\u2014(CH2)mR13, CHO, CO\u2014(C3-C7)-cycloalkyl, COR12, COR13, SO2R14, (C1-C6)-alkyl or CO\u2014(C1-C6)-alkyl, which last two mentioned groups are unsubstituted or substituted by one or more R15 radicals;
R8a and R9a are each independently H, (C2-C7) alkenyl, (C2-C6)-haloalkenyl, (C2-C6)-alkynyl, (C2-C6)-haloalkynyl, (C3-C7)-cycloalkyl or (C1-C6)-alkyl, which last mentioned group is unsubstituted or substituted by one or more R15 radicals;
R10 and R11 are each independently (C2-C6)-alkenyl, (C2-C6)-haloalkenyl, (C2-C6)-alkynyl, (C2-C6)-haloalkynyl, (C3-C7)-cycloalkyl or (C1-C6)-alkyl, which last mentioned group is unsubstituted or substituted by one or more R15 radicals;
Y is (C1-C18)-alkylene, (C4-C18)-alkenylene or (C4-C18)-alkynylene, which groups are unsubstituted or substituted by one or more R16 radicals, and in which 1, 2, 3 or 4 non-adjacent chain atoms are optionally replaced by a heteroatom selected from NR17, O and S(O)n, with the proviso that said heteroatom is not the terminal atom of the Y moiety; or (C1-C3)-alkyleneu-(C3-C7)-cycloalkylene-(C1-C3)-alkylenev, which cycloalkylene portion is unsubstituted or substituted by one or more halogen or (C1-C6)-alkyl radicals; or (C1-C3)-alkyleneu-phenylene-(C1-C3)-alkylenev, which phenylene portion is unsubstituted or substitute by one or more radicals selected from the group consisting of halogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C1-C6)-alkoxy, (C1-C6)-haloalkoxy, CN, NO2, S(O)pR18 and NR19R20; or (C1-C3)-alkyleneu-heteroarylene-(C1-C3)-alkylenev which heteroarylene portion is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C1-C6)-alkoxy, (C1-C6)-haloalkoxy, NO2, CN, CO2(C1-C6)-alkyl, S(O)pR18, OH and oxo; or S, S2, SO or SO2;
Y1 is Y with the exclusion of S, S2, SO or SO2; or (C1-C6)-alkylene-CO\u2014O\u2014(C1-C6)-alkylene-O\u2014CO\u2014(C1-C6)-alkylene;
X is O or S;
R12 is phenyl unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl (C1-C6)-alkoxy, (C1-C6)-haloalkoxy, CN, NO2, S(O)pR18 and NR19R20;
R13 is heterocycyl unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, NO2, CN, CO2(C1-C6-alkyl, S(O)pR18, OH and oxo;
R14 is (C3-C7)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-haloalkenyl, (C2-C6)-alkynyl, (C2-C6)-haloalkynyl, R12 or R13; or is (C1-C6)-alkyl unsubstituted or substituted by one or more R15 radicals;
R15 is halogen, (C1-C6)-alkoxy, (C1-C6) haloalkoxy, (C3-C6 alkenyloxy, (C3-C6)-haloalkenyloxy, (C3-C6)-alkynyloxy, (C3-C6)-haloalkynyloxy, (C3-C7)-cycloalkyl, S(O)pR21, CN, NO2, OH, R12, R13, COR19, NR19, R20, OR12, OR13, CO2H or CO2R18;
R16 is halogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C2-C6)-alkenyl, (C2-C6)-haloalkenyl, (C2-C6)-alkynyl, (C2-C6)-haloalkynyl, (C3-C7)-cycloalkyl, (C3-C7)-cycloalkyl-(C1-C4)-alkyl, (CH2)qR12 or (CH2)qR13;
R17 is H or (C1-C6)-alkyl;
R18 is (C1-C6)-alkyl or (C1-C6)-haloalkyl;
R19 and R20 are each independently H, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C3-C6)-alkenyl, (C3-C6)-haloalkenyl, (C3-C6)-alkynyl, (C3-C7)-cycloalkyl or (C3-C7)-cycloakyl(C1-C6)-alkyl; or
R19 and R20 together With the attached N atom form a five- or six-membered saturated ring which optionally contains an additional hetero atom in the ring which is selected from O, S and N, the ring being unsubstituted or substituted by one or C6)-haloalkyl;
R21 is (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C2-C6)-alkenyl, (C2-C6)-haloalkenyl, (C2-C6)-alkynyl, (C2-C6)-haloalkynyl, (C3-C7)-cycloalkyl, (C3-C7)-cycloalkyl-(C1-C4)-alkyl, (CH2)qR12 or (CH2)qR13;
Z is H, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C3-C6)-alkenyl, (C3-C6)-alkynyl, (CH2)qR12, COR18, CO2\u2014(C1-C6)-alkyl or SO2R18;
Q is (C1-C6)-alkyl or CH2R12;
n, p, r and s are each independently zero, one or two;
m, q, u and V are each independently zero or one;
t is 0, 1, 2 or 3; and
each heterocyclyl in the above-mentioned radicals is independently a heterocyclic radical having 3 to 7 ring atoms and 1, 2 or 3 hetero atoms in the ring selected from the group consisting of N, O and S;
or a pesticidally acceptable salt thereof.
2. A compound or a salt thereof as claimed in claim 1 wherein R1 and R1a are each CN.
3. A compound or a salt thereof as claimed in claim 1 wherein W and W1 are each C\u2014Cl.
4. compound or a salt thereof as claimed in claim 1, wherein:
R1 and R1a are each CN;
W is and W1 are each C-halogen;
R2 and R2a are each Cl;
R3, R3a, R4 and R4a are each CF3;
A is NR8\u2014Y\u2014NR9, or a formula (F):
M is Y, CO\u2014Y1\u2014CO, CO\u2014O\u2014Y1\u2014O\u2014CO, CO\u2014CO, C(\u2550X), S, S2, SO or SO2;
R8 and R9 are each independently H, (C3-C7)-cycloalkyl, CO2\u2014(C1-C6)-alkyl, CO2\u2014(C3-C6)-alkenyl, CO2\u2014(C2-C6)-alkynyl, CO2\u2014(CH2)mR12, CHO, CO\u2014(C3-C7)-cycloalkyl, COR12, COR13, SO2R14, (C1-C6)-alkyl or CO\u2014(C1-C6)-alkyl, which last two mentioned groups are unsubstituted or substituted by one or more R15 radicals;
R8a and R9a are each independently H, (C3-C7)-cycloalkyl or (C1-C6)-alkyl, which last mentioned group is unsubstituted or substituted by one or more R15 radicals;
R10 and R11 are each independently H, (C1-C6)-alkyl or (C1-C6)-alkyl, which last two mentioned group are unsubstituted or substituted by one or more R15 radicals;
Y and Y1 are each independently C1-C18)-alkylene or (C4-C18)-alkenylene, which 2, 3 or 4 non-adjacent chain atoms are optionally replaced by a heteroatom selected from NR17, and O and S(O)n, with the proviso that said heteroatom is not the terminal atom of the Y moiety; or (C1-C3)-alkyleneu-(C3-C7)-cycloalkylene-(C1-C3)-alkylenev, which cycloalkylene portion is unsubstituted or substituted by one or more halogen or (C1-C6)-alkoxy, radicals; or (C1-C3)-alkyleneu-phenylene-(C1-C3)-alkylenev, which phenylene portion is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C6)-alkyl (C1-C6)-haloalkyl, (C1-C6)-alkoxy, (C1-C6)-haloalkoxy, CN, NO2, S(O)pR18 and NR19R20; or (C1-C3)-alkyleneu-heteroarylene-(C1-C3)-alkylenev, which heteroarylene portion is unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C1-C6-alkoxy, (C1-C6)-haloalkoxy, NO2CN, CO2(C1-C6)-alkyl, S(O)pR18, OH and oxo;
X is O;
R12 is phenyl unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy CN, NO2, S(O)pR18 and NR19R20;
R13 is heterocyclyl unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy, NO2, CN, CO2(C1-C3)-alkyl, S(O)pR18, OH and oxo;
R14 is (C3-C7)-cycloalkyl, (C2-C3) alkenyl, (C1-C3)-haloalkenyl, (C2-C3)-alkynyl, (C2-C3)-haloalkynyl, R12 or R13; or is (C1-C3)-alkyl unsubstituted or substituted by one or more R15 radicals;
R15 is halogen, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy, (C3-C4)-alkenyloxy, (C3-C4)-haloalkenyloxy, (C1-C4)-alkynyloxy, (C3-C4)-haloalkynyloxy, (C3-C4)-cycloalkyl, S(O)pR21, CN, NO2, OH, R12, R13, COR19, NR19R20, OR12, OR13, CO2H or CO2R18;
R16 is halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C2-C4)-alkenyl, (C2-C4)-haloalkenyl, (C2-C4)-alkynyl, (C2-C4)-haloalkynyl, (C3-C7)-cycloalkyl (C3-C7)-cycloalkyl-(C1-C3)-alkyl, (CH2)qR12 or (CH2)qR13;
R17 is H or (C1-C3)-alkyl;
R18 and R21 are each independently (C1-C3)-alkyl or (C1-C3)-haloalkyl; and
R19 and R20 are each independently H, (C1-C3-alkyl, (C1-C3)-haloalkyl, (C3-C4)\u2014alkenyl, (C3-C4)-haloalkenyl, (C3-C4)-alkynyl, (C1-C7)-cycloalkyl or (C3-C7)-cycloalkyl-(C1-C3)-alkyl; or
R19 and R20 together with the attached N atom form a five- or six-membered saturated ring which optionally contains an additional hetero atom in the ring which is selected from O, S and N, the ring being unsubstituted or substituted by one or more radicals selected from the group consisting of halogen, (C1-C3)-alkyl and (C1-C3)-haloalkyl.
5. A compound or a salt thereof as claimed in claim 1 wherein: each pair of corresponding substituents R1 and R1a, R2 and R2a, R3 and R3a, R4 and R4a, W and W1 and n and s has the same value.
6. A process for the preparation of a compound of formula (1) or a salt thereof as defined in claim 1, which process comprises:
a) where R1 and R1a are each independently CN, CH3 or CF3, A is NR8a\u2014CO\u2014O\u2014Y1\u2014O\u2014CO\u2014NR9a and the other values are as defined in claim 1, reacting a compound of formula (II):
wherein R1 is CN, CH3 or CF3 and the other values are as defined in claim 1, with a compound of formula (III):
L-CO\u2014O\u2014Y1\u2014O\u2014CO-L\u2003\u2003(III)
wherein Y1 is as defined in claim 1 and L is a leaving group; or
b) where R1 and R1a are each independently CN, CH3 or CF3, A is NR8a\u2014CO\u2014O\u2014Y1 \u2014O\u2014CO\u2014NR9a and the other values are as defined in claim 1, reacting a compound of formula (II) above with a compound of formula (IV):
HO\u2014Y1\u2014O\u2014H\u2003\u2003(IV)
wherein Y1 is as defined in claim 1, in the presence of phosgene, and a base; or
c) where R1 and R1a are each independently CN, CH3 or CF3, A is NR8a\u2014CO\u2014Y1\u2014CO\u2014NR9a and the other values are as defined in claim 1, reacting a compound of formula (II) as defined above, with a compound of formula (V):
L1-CO\u2014Y1\u2014CO-L1\u2003\u2003(V)
wherein Y1 is as defined in claim 1 and L1 is a leaving group; or
d) where R1 is R1 and R1a are each independently CN, CH3 or CF3, A is NR8\u2014Y\u2014NR9 or a formula (F), and the other values are as defined in claim 1, reacting a compound of formula (VI);
wherein L2 is a leaving group and the other values are as defined in claim 1, with a compound of formula (VII) or (VIII):
HNR8\u2014Y\u2014NHR9\u2003\u2003(VII)
wherein Y1 is as defined in claim 1 and L is a leaving group; or
b) where R1 and R1a are each independently CN, CH3 or CF3, A NR8a\u2014CO\u2014O\u2014Y1\u2014O\u2014CO\u2014NR9a and the other values are as defined in claim 1, reacting a compound of formula (II) above with a compound of formula (IV):
HO\u2014Y1\u2014O\u2014H\u2003\u2003(IV)
wherein Y1 is as defined in claim 1, in the present of phosgene and a base; or
c) where R1 and R1a are each independently CN, CH3 or CF3, A is NR8a\u2014CO\u2014Y1\u2014CO\u2014NR9a and the other values are as defined in claim 1, reacting a compound of formula (II) as defined above, with a compound of formula (V):
L1-CO\u2014Y1\u2014CO-L1\u2003\u2003(V)
wherein Y1 is as defined in claim 1 and L1 is a leaving group; or
d) where R1 is R1 and R1a are each independently CN, CH3 or CF3, A is NR8\u2014Y\u2014NR9 or a formula (F), and the other values are as defined in claim 1, reacting a compound of formula (VI):
wherein L2 is a leaving group and the other values are as defined in claim 1, with a compound of formula (VII) or (VIII):
HNR8\u2014Y\u2014NHR9\u2003\u2003(VII)
wherein the various values are as defined in claim 1; or
e) where R1 and R1a are each independently CN, CH3 or CF3, A is a formula (F),
M is C(\u2550X) and the other values are as defined in claim 1, reacting a compound of formula (IX):
wherein the various values are as defined in claim 1, with phosgene or thiophosgene, in the presence of a base; or
f) where R1 and R1a are each independently CN CH3 or CF3, A is a formula (E) and the other values are as defined in claim 1; reacting a corresponding compound of formula (I) in which A is NHCH2CH2NH and the other values are as defined in claim 1, with a compound of formula (X):
L3-CO\u2014(CH2)t\u2014CO-L3\u2003\u2003(X)
wherein L3 is a leaving group and t is as defined in claim 1; or
g) where R1 and R1a are each independently CN, CH3, or CF3, A is
NR10\u2014C(\u2550X)\u2014NR11 and the other values are as defined in claim 1, alkylating a corresponding compound of formula (I) in which (A) is replaced by NR10\u2014C(\u2550X)\u2014NH, with a compound of formula (XI):
R11-L4\u2003\u2003(XI)
wherein R11 is as defined in claim 1 and L4 is a leaving group; or
h) where R1 and R1a are each independently CN, CH3 or CF3, A is NR10\u2014C(\u2550X)\u2014NR11 wherein the various values are as defined in claim 1, reacting a compound of formula (XII):
wherein the various values are as defined in claim 1, with phosgene or thiophosgene, in the presence of a base; or
i) where R1 and R1a are each independently CN, CH3 or CF3, A is NR8a\u2014CO\u2014CO\u2014NR9a and the other values are as defined in claim 1, reacting a compound of formula (II) as defined above, with a compound of formula (XIII):
L5-CO\u2014CO-L5\u2003\u2003(XIII)
wherein L5 is a leaving group; or
j) where R1 and R1a are each independently CN, CH3 or CF3, A is NR8\u2014CH2\u2014NR9, and R8, R9 and the other values are as defined in claim 1, reacting a compound of formula (XII) as defined above, with formaldehyde or its oligomers, in the presence of an acid; or
k) where one or both of R1 and R1a is CSNH2, and the other values are as defined in claim 1, reacting the corresponding compound of formula (I) wherein one or both of R1 and R1a is CN, with an alkali or alkaline earth metal hydrosulfide, or with H2S in the presence of an organic base, or with the reagent Ph2PS2; or
l) where one or both of R1 and R1a is CSNH2, and the other values are as defined in claim 1, reacting the corresponding compound of formula (I) wherein one or both of R1 and R1a is CN, with a bis(trialkylsilyl)sulfide in the presence of a base; or
m) where one or both of R1 and R1a is C(\u2550N\u2014H)\u2014S-Q, and the other values are as defined in claim 1, reacting the corresponding compound of formula (I) wherein one or both of R1 and R1a is CSNH2 with an alkylating agent of formula (XIV) or (XV):
Q-L5\u2003\u2003(XIV)
Q3O+BF4\u2212\u2003\u2003(XV)
where Q is as defined in claim 1 and L5 is a leaving group; or
n) where one or both of R1 and R1a is C(\u2550N-Z)-S-Q, Z 7 is as defined in claim 1 with the exclusion of H, and the other values are as defined in claim 1, alkylating, acylating or sulfonylating the corresponding compound of formula (I) wherein Z is H, with a compound of formula (XVI):
Z-L6\u2003\u2003(XVI)
wherein Z is as defined in claim 1 with the exclusion of H, and L6 is a leaving group; or
o) where R1 and R1a are each independently CN, CH3 or CF3, n andor s is 1 or 2, and the other values are as defined in claim 1, oxidising the corresponding compound in which n andor s is 0 or 1; and
p) if desired, converting a respecting compound of formula (I) into a pesticidally acceptable salt thereof.
7. A pesticidal composition comprising a compound of formula (I) or a pesticidally acceptable salt thereof as defined in claim 1, in association with a pesticidally acceptable diluent or carrier andor surface active agent.
8. The use of a compound of formula (I) or a salt thereof according to claim 1, for the preparation of a veterinary medicament.
9. The use of a compound of formula (I) or a salt thereof according to claim 1, for the control of pests.
10. A method for controlling pests at a locus which comprises applying thereto an effective amount of a compound of formula (I) or a salt thereof as claimed in claim 1.